DF
ELV icon

Donoghue Forlines’s Elevance Health ELV Stock Holding History

Donoghue Forlines’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,271
Closed -$599K – 238
2023
Q4 		$599K Sell
1,271
-422
-25% -$195K 0.19% 144
2023
Q3 		$737K Buy
+1,693
New +$768K 0.26% 107
2022
Q4 		– Sell
-1,414
Closed -$642K – 235
2022
Q3 		$642K Buy
+1,414
New +$677K 0.23% 76
2018
Q4 		– Sell
-9,612
Closed -$2.63M – 67
2018
Q3 		$2.63M Buy
+9,612
New +$2.5M 0.21% 86

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Donoghue Forlines's ELV Position: Q1 2024 in Review

Donoghue Forlines sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 1,271 shares — an estimated $599K sold.

Donoghue Forlines first reported a position in ELV in Q3 2018 and held it in 4 quarters. The position peaked at $2.63M in Q3 2018. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Donoghue Forlines reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Donoghue Forlines sold 1,271 Elevance Health shares in Q1 2024, an estimated $599K.
  • Donoghue Forlines first reported a position in Elevance Health in Q3 2018 and held it in 4 quarters.
  • Donoghue Forlines's Elevance Health position peaked at $2.63M in Q3 2018.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Donoghue Forlines's 13F filing for Q1 2024, filed 7 May 2024.